Adamas Pharmaceuticals

Adamas Pharmaceuticals

Create and commercialize a new generation of medicines intended to lessen the burden of chronic neurologic diseases on patients, caregivers and society using its deep understanding of time-dependent biology.

Launch date
Employees
Market cap
-
Enterprise valuation
CAD545m (Public information from Oct 2021)
Emeryville California (HQ)
Authorizing premium user...